Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Eastman Kodak Company    

SummaryNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets

WSJ BLOG/Health: A.M. Vitals: FDA Adds a Warning, Removes Another From Statin Labels

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/29/2012 | 03:13pm CEST

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Katherine Hobson

The FDA and Statins: The FDA will require drug makers to add to statin labels a warning about a small increase in the risk of increased blood-sugar levels and of diabetes linked to the drugs, the WSJ reports. The labels will also include the information that some patients have experienced an adverse reaction of memory loss and confusion, though that won't be a full-fledged warning. But the FDA also removed a warning about the need for liver-enzyme monitoring from statin labels. Cardiologists tell the paper that most people should keep taking their statins despite the new label information.

Benefit Cuts at Kodak: Eastman Kodak is proposing to end health-care benefits for about 16,000 Medicare-eligible retirees in order to save about $20.5 million annually, the Associated Press reports. Kodak filed for Chapter 11 last month.

Insurer and Physicians' Group Clash: Insurer Blue Shield of California filed a demand for at least $10.5 million in damages from Monarch HealthCare, a physician association that sold its management arm to a unit of UnitedHealth Group, the WSJ reports. Blue Shield alleges that Monarch tried to direct Blue Shield members into competing health plans and that physicians stopped seeing some members, violating the contract between Blue Shield and Monarch. Monarch says it objects to "the mischaracterizations made by Blue Shield," the paper says. The case was submitted for binding arbitration.

The Right Dose of Selenium: A review of previously published research appearing in the Lancet suggests that large doses of selenium supplements could raise the risk for type 2 diabetes, Bloomberg News reports. The author of the review suggests that people with blood selenium levels of 122 micrograms per liter or higher shouldn't supplement with the mineral, which has been associated with a lower risk of some cancers, BN says.

Image: iStockphoto

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

Stocks mentioned in the article : Eastman Kodak Company
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EASTMAN KODAK COMPANY
08/15 EARNINGS REVIEW AND FREE RESEARCH RE : Post Earnings Coverage as Apple’s Q..
08/10 EASTMAN KODAK : An Application for the Trademark "NEXPRESS" Has Been Filed by Ea..
08/10 EASTMAN KODAK : Trademark Application for "NEXFINITY" Filed by Eastman Kodak Com..
08/09 EASTMAN KODAK : Kodak posts 2Q profit
08/09 EASTMAN KODAK CO : Results of Operations and Financial Condition, Financial Stat..
08/09 EASTMAN KODAK : Management's Discussion and Analysis of Financial Condition and ..
08/09 EASTMAN KODAK : Kodak Reports Q2 Net Earnings of $4 Million and Strong Performan..
08/09 EASTMAN KODAK COMPANY : Investor Network: Eastman Kodak Company to Host Earnings..
08/02 EASTMAN KODAK : Kodak to Report Second-Quarter 2017 Financial Results on August ..
08/02 EASTMAN KODAK : A Queens World Film Festival 8 Update
More news
Income Statement Evolution
Managers
NameTitle
Jeff J. Clarke Chief Executive Officer & Director
James V. Continenza Chairman
David Bullwinkle Chief Financial Officer & Senior Vice President
Kim E. VanGelder Chief Information Officer & Senior Vice President
Terry R. Taber Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
EASTMAN KODAK COMPANY310
LARGAN PRECISION CO., LTD.--.--%24 846
Q TECHNOLOGY GROUP CO LTD268.00%2 063
GOPRO INC4.02%1 311
YESTAR HEALTHCARE HOLDINGS CO LTD-6.95%968
VITEC GROUP PLC52.66%569